Douglas Conrad
Overview
Explore the profile of Douglas Conrad including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
48
Citations
1422
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Silverman E, Kim A, Make B, Regan E, Morrow J, Hersh C, et al.
NPJ Genom Med
. 2023 Oct;
8(1):36.
PMID: 37903807
The consequences of returning infectious pathogen test results identified incidentally in research studies have not been well-studied. Concerns include identification of an important health issue for individuals, accuracy of research...
2.
Wood S, Conrad D, Grembowski D, Coe N, Fishman P, Teutsch E
Hosp Top
. 2023 Mar;
102(4):237-249.
PMID: 36861790
The Centers for Medicare and Medicaid Innovation (CMMI) gave rise to the State Innovation Models (SIMs). Medicaid Integrated Purchasing for Physical and Behavioral Health, referred to as Payment Model 1...
3.
Tamma P, Souli M, Billard M, Campbell J, Conrad D, Ellison D, et al.
Trials
. 2022 Dec;
23(1):1057.
PMID: 36578069
Background: Bacteriophages (phages) are a promising anti-infective option for human disease. Major gaps remain in understanding their potential utility. Methods: This is a randomized, placebo-controlled, double-blind study of a single...
4.
Salinas D, Wee C, Bailey B, Raraigh K, Conrad D
Ann Am Thorac Soc
. 2022 Nov;
20(4):523-531.
PMID: 36409994
Variants within the cystic fibrosis (CF) transmembrane conductance regulator gene, , that are of unknown significance or are categorized as non-CF causing may be observed in persons with CF. These...
5.
Lowers J, Dellon E, Stephenson A, Arnold R, Althouse A, Jeong K, et al.
BMJ Open Respir Res
. 2022 Sep;
9(1).
PMID: 36126995
Introduction: Cystic fibrosis (CF) is a life-limiting genetic disorder estimated to affect more than 160 000 individuals and their families worldwide. People living with CF commonly experience significant physical and...
6.
Ghuneim L, Raghuvanshi R, Neugebauer K, Guzior D, Christian M, Schena B, et al.
ISME J
. 2022 May;
16(9):2065-2075.
PMID: 35597889
Antibiotics are our primary approach to treating complex infections, yet we have a poor understanding of how these drugs affect microbial communities. To better understand antimicrobial effects on host-associated microbial...
7.
Metersky M, Choate R, Aksamit T, Conrad D, Lapinel N, Maselli D, et al.
Respir Med
. 2022 Feb;
193:106746.
PMID: 35124355
Introduction: Little information is available about Stenotrophomonas maltophilia in patients with bronchiectasis. We analyzed data from the US Bronchiectasis and NTM Research Registry to determine its prevalence and association with...
8.
Silveira C, Cobian-Guemes A, Uranga C, Baker J, Edlund A, Rohwer F, et al.
Int J Mol Sci
. 2021 Nov;
22(21).
PMID: 34769481
Ecological networking and in vitro studies predict that anaerobic, mucus-degrading bacteria are keystone species in cystic fibrosis (CF) microbiomes. The metabolic byproducts from these bacteria facilitate the colonization and growth...
9.
Luong T, Schumann A, Conrad D, Roach D
Microbiol Resour Announc
. 2021 Sep;
10(36):e0057221.
PMID: 34498926
Here, we report the genome sequence of PA291, a nonmucoid, multidrug-resistant strain of Pseudomonas aeruginosa isolated from cystic fibrosis sputum. Short reads were assembled into 190 contigs and scaffold assembled...
10.
Grembowski D, Conrad D, Naranjo D, Wood S, Zhou L, Banks J, et al.
J Health Care Poor Underserved
. 2021 Jun;
32(2):862-891.
PMID: 34120982
The Washington State Innovation Models (SIM) $65 million Test Award from the Center for Medicare & Medicaid Services' Innovation Center is a statewide intervention expected to improve population health, quality...